Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis

BACKGROUND: Paediatric-onset multiple sclerosis (POMS) therapeutic approach derives from of adult-onset multiple sclerosis (AOMS) tailored algorithms. OBJECTIVES: To evaluate in a common clinical scenario the efficacy and safety of alemtuzumab (ALZ) in POMS and AOMS. METHODS: All patients switching...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthenparampil, Marco, Gaggiola, Marta, Miscioscia, Alessandro, Mauceri, Valentina Annamaria, De Napoli, Federica, Zanotelli, Giovanni, Anglani, Mariagiulia, Nosadini, Margherita, Sartori, Stefano, Perini, Paola, Rinaldi, Francesca, Gallo, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559704/
https://www.ncbi.nlm.nih.gov/pubmed/37808246
http://dx.doi.org/10.1177/17562864231177196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559704/
https://www.ncbi.nlm.nih.gov/pubmed/37808246
http://dx.doi.org/10.1177/17562864231177196

Ejemplares similares